Amneal Pharmaceuticals share price today
(NASDAQ: AMRX)

Name: Amneal Pharmaceuticals Share Price Today (NASDAQ: AMRX) - Amneal Pharmaceuticals Stock Price Live Quote | INDmoney
Brand: INDmoney
Rating: 4.7 (371551 reviews)

Amneal Pharmaceuticals share price is $8.82 & ₹762.84 as on 24 Jan 2025, 2.30 'hrs' IST

$8.82

▲

0.3

(3.52%)

Market is closed - opens 8 PM, 24 Jan 2025

View live Amneal Pharmaceuticals share price in Dollar and Rupees. Guide to invest in Amneal Pharmaceuticals stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Amneal Pharmaceuticals, along with analyst recommendations, forecasts, and comprehensive financials.

Amneal Pharmaceuticals share price movements

Today's Low: $8.42
Today's High: $9.04
$8.82
4.54%
Downside
Day's Volatility :6.81%
Upside
2.38%
52 Weeks Low: $5.01
52 Weeks High: $9.48
$8.82
43.2%
Downside
52 Weeks Volatility :47.12%
Upside
6.91%

Amneal Pharmaceuticals Returns

Period	Amneal Pharmaceuticals Inc.	Sector (Health Care)	Index (Russel 2000)
3 Months	1.43%	-5.5%	0.0%
6 Months	14.52%	-4.3%	0.0%
1 Year	55.76%	1.6%	0.0%
3 Years	89.76%	9.8%	-11.0%

Amneal Pharmaceuticals Key Statistics

in dollars & INR

Previous Close	$8.52
Open	$8.45
Today's High	$9.035
Today's Low	$8.42
Market Capitalization	$3.9B
Today's Volume	$818.4K
52 Week High	$9.475
52 Week Low	$5.01
Revenue TTM	$2.7B
EBITDA	$566.8M
Earnings Per Share (EPS)	$-0.86
Profit Margin	-6.88%
Quarterly Earnings Growth YOY	-0.75%
Return On Equity TTM	-185.77%

How to invest in Amneal Pharmaceuticals Stock (AMRX) from India?

It is very easy for Indian residents to invest directly in Amneal Pharmaceuticals from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Amneal Pharmaceuticals stock in both Indian Rupees (INR) and US Dollars (USD). Search for Amneal Pharmaceuticals or AMRX on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Amneal Pharmaceuticals or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Amneal Pharmaceuticals shares which would translate to 0.098 fractional shares of Amneal Pharmaceuticals as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Amneal Pharmaceuticals, in just a few clicks!

Returns in Amneal Pharmaceuticals for Indian investors in Rupees

Investment Value

₹1,00,000

Amneal Pharmaceuticals investment value today

Current value as on today

₹1,65,298

Returns

₹65,298

(+65.3%)

Returns from Amneal Pharmaceuticals Stock

₹61,243 (+61.24%)

Dollar Returns

₹4,054 (+4.05%)

Indian investors sentiment towards Amneal Pharmaceuticals

-39%

Period: Oct 25, 2024 to Jan 23, 2025. Change in 30 Days versus previous period

Search volume for Amneal Pharmaceuticals on INDmoney from India has reduced in the last 30 days as on Jan 24, 2025. -39% less investors are searching Amneal Pharmaceuticals in the last 30 days versus the previous period.

Global Institutional Holdings in Amneal Pharmaceuticals

UBS Group AG
7.03%
Vanguard Group Inc
4.72%
BlackRock Inc
4.01%
TPG GP A, LLC
3.98%
Rubric Capital Management LP
3.46%
Citadel Advisors Llc
2.87%

Analyst Recommendation on Amneal Pharmaceuticals

Buy

81%Buy

9%Hold

9%Sell

Based on 11 Wall street analysts offering stock ratings for Amneal Pharmaceuticals(by analysts ranked 0 to 5 stars)

Based on 11 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Amneal Pharmaceuticals

What analysts predicted

Upside of 19.05%

Target:

$10.50

Current:

$8.82

Insights on Amneal Pharmaceuticals

Price Movement
In the last 3 years, AMRX stock has moved up by 91.0%
Increasing Revenue
Revenue is up for the last 4 quarters, 616.98M → 702.46M (in $), with an average increase of 4.2% per quarter
Decreasing Net Profit
Netprofit is down for the last 2 quarters, 5.99M → -156.0K (in $), with an average decrease of 102.6% per quarter
AMRX vs ITCI (1 yr)
In the last 1 year, Intra-cellular Therapies, Inc. has given 91.3% return, outperforming this stock by 35.8%
AMRX vs ITCI (3 yr)
In the last 3 years, Intra-cellular Therapies, Inc. has given 198.1% return, outperforming this stock by 107.1%
Price to Sales
ForAMRX every $1 of sales, investors are willing to pay $0.9, whereas for Intra-cellular Therapies, Inc., the investors are paying $20.9 for every $1 of sales.

Amneal Pharmaceuticals Financials in INR & Dollars

	FY18	Y/Y Change
Revenue	$1.7B	↑ 60.88%
Net Income	$-169.7M	↓ 201.24%
Net Profit Margin	-10.21%	↓ 26.43%

	FY19	Y/Y Change
Revenue	$1.6B	↓ 2.2%
Net Income	$-603.6M	↑ 255.62%
Net Profit Margin	-37.11%	↓ 26.9%

	FY20	Y/Y Change
Revenue	$2.0B	↑ 22.51%
Net Income	$68.6M	↓ 111.36%
Net Profit Margin	3.44%	↑ 40.55%

	FY21	Y/Y Change
Revenue	$2.1B	↑ 5.08%
Net Income	$20.2M	↓ 70.59%
Net Profit Margin	0.96%	↓ 2.48%

	FY22	Y/Y Change
Revenue	$2.2B	↑ 5.67%
Net Income	$-254.8M	↓ 1363.21%
Net Profit Margin	-11.52%	↓ 12.48%

	FY23	Y/Y Change
Revenue	$2.4B	↑ 8.2%
Net Income	$-84.0M	↓ 67.03%
Net Profit Margin	-3.51%	↑ 8.01%

	Q2 FY23	Q/Q Change
Revenue	$599.0M	↑ 7.44%
Net Income	$11.9M	↓ 218.06%
Net Profit Margin	1.99%	↑ 3.8%

	Q3 FY23	Q/Q Change
Revenue	$620.0M	↑ 3.5%
Net Income	$9.7M	↓ 18.75%
Net Profit Margin	1.56%	↓ 0.43%

	Q4 FY23	Q/Q Change
Revenue	$617.0M	↓ 0.49%
Net Income	$-98.6M	↓ 1118.89%
Net Profit Margin	-15.99%	↓ 17.55%

	Q1 FY24	Q/Q Change
Revenue	$659.2M	↑ 6.84%
Net Income	$-91.6M	↓ 7.1%
Net Profit Margin	-13.9%	↑ 2.09%

	Q2 FY24	Q/Q Change
Revenue	$701.8M	↑ 6.46%
Net Income	$6.0M	↓ 106.54%
Net Profit Margin	0.85%	↑ 14.75%

	Q3 FY24	Q/Q Change
Revenue	$702.5M	↑ 0.1%
Net Income	$-156.0K	↓ 102.6%
Net Profit Margin	-0.02%	↓ 0.87%

	FY18	Y/Y Change
Profit	$716.4M	↑ 36.15%

	FY19	Y/Y Change
Profit	$353.0M	↓ 50.73%

	FY20	Y/Y Change
Profit	$628.4M	↑ 78.02%

	FY21	Y/Y Change
Profit	$769.0M	↑ 22.37%

	FY22	Y/Y Change
Profit	$784.7M	↑ 2.05%

	FY23	Y/Y Change
Profit	$820.6M	↑ 4.57%

	Q2 FY23	Q/Q Change
Profit	$220.0M	↑ 23.48%

	Q3 FY23	Q/Q Change
Profit	$232.5M	↑ 5.69%

	Q4 FY23	Q/Q Change
Profit	$189.8M	↓ 18.36%

	Q1 FY24	Q/Q Change
Profit	$238.1M	↑ 25.41%

	Q2 FY24	Q/Q Change
Profit	$249.9M	↑ 4.99%

	Q3 FY24	Q/Q Change
Profit	$269.6M	↑ 7.85%

	FY18	Y/Y Change
Operating Cash Flow	$250.2M	↑ 6.85%
Investing Cash Flow	$-396.4M	↑ 302.19%
Financing Cash Flow	$287.7M	↓ 402.77%

	FY19	Y/Y Change
Operating Cash Flow	$1.7M	↓ 99.32%
Investing Cash Flow	$-19.6M	↓ 95.06%
Financing Cash Flow	$-45.8M	↓ 115.93%

	FY20	Y/Y Change
Operating Cash Flow	$379.0M	↑ 22128.8%
Investing Cash Flow	$-317.5M	↑ 1521.79%
Financing Cash Flow	$131.8M	↓ 387.58%

	FY21	Y/Y Change
Operating Cash Flow	$241.8M	↓ 36.2%
Investing Cash Flow	$-194.2M	↓ 38.85%
Financing Cash Flow	$-138.1M	↓ 204.79%

	FY22	Y/Y Change
Operating Cash Flow	$65.1M	↓ 73.08%
Investing Cash Flow	$-174.3M	↓ 10.23%
Financing Cash Flow	$-106.6M	↓ 22.81%

	Q2 FY23	Q/Q Change
Operating Cash Flow	$-11.3M	↓ 108.12%
Investing Cash Flow	$-12.3M	↑ 4.66%
Financing Cash Flow	$-12.3M	↓ 4.99%

Amneal Pharmaceuticals Technicals Summary

Sell

Neutral

Buy

Amneal Pharmaceuticals is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Amneal Pharmaceuticals Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Amneal Pharmaceuticals Inc.	8.54%	14.52%	55.76%	89.76%	84.82%
Intra-cellular Therapies, Inc.	49.17%	58.17%	89.83%	172.62%	447.12%
Haleon Plc Spon Ads	-5.34%	-0.11%	14.11%	24.43%	24.43%
Zoetis Inc.	0.67%	-7.35%	-11.05%	-14.66%	22.56%
Neurocrine Biosciences Inc.	5.56%	-0.03%	4.08%	93.28%	48.77%
Viatris Inc.	-11.31%	-7.78%	-5.11%	-24.11%	-31.82%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Amneal Pharmaceuticals Inc.	89.83	NA	NA	0.61	-1.86	0.06	NA	-0.3
Intra-cellular Therapies, Inc.	NA	NA	0.0	-0.7	-0.1	-0.07	NA	10.8
Haleon Plc Spon Ads	28.0	28.0	1.65	0.36	0.07	0.04	0.02	1.82
Zoetis Inc.	31.32	31.32	2.61	5.88	0.47	0.15	0.01	11.59
Neurocrine Biosciences Inc.	39.03	39.03	0.34	6.6	0.16	0.12	NA	26.87
Viatris Inc.	224.4	NA	0.07	2.69	-0.04	0.02	0.04	16.58

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Amneal Pharmaceuticals Inc.	Buy	$3.9B	84.82%	89.83	-6.88%
Intra-cellular Therapies, Inc.	Buy	$13.4B	447.12%	NA	-14.07%
Haleon Plc Spon Ads	Buy	$41.8B	24.43%	28.0	10.75%
Zoetis Inc.	Buy	$75.2B	22.56%	31.32	26.55%
Neurocrine Biosciences Inc.	Buy	$14.9B	48.77%	39.03	17.21%
Viatris Inc.	Hold	$13.5B	-31.82%	224.4	-5.87%

About Amneal Pharmaceuticals

Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, manufactures, markets, and distributes generics, injectables, biosimilars, and specialty branded pharmaceutical products worldwide. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment offers immediate and extended release oral solid, powder, liquid, sterile injectable, nasal spray, inhalation and respiratory, biosimilar, ophthalmic, film, transdermal patch, and topical products. The Specialty segment develops, promotes, sells, and distributes pharmaceutical products with focus on central nervous system disorders, including Parkinson's disease, and endocrine disorders. This segment also provides Rytary, an oral capsule formulation of carbidopa-levodopa to treat Parkinson's disease, post-encephalitic parkinsonism, and parkinsonism; Unithroid for the treatment of hypothyroidism; and IPX203, a pipeline product for Parkinson's disease. The AvKARE segment offers pharmaceuticals, medical and surgical products, and services primarily to governmental agencies, the Department of Defense, and the Department of Veterans Affairs. This segment also distributes bottle and unit dose pharmaceuticals under the AvKARE and AvPAK names; and packages and distributes pharmaceuticals and vitamins to its retail and institutional customers. It sells its products through wholesalers, distributors, hospitals, chain pharmacies, and individual pharmacies. The company was formerly known as Atlas Holdings, Inc. and changed its name to Amneal Pharmaceuticals, Inc. in 2018. Amneal Pharmaceuticals, Inc. was founded in 2002 and is headquartered in Bridgewater, New Jersey.

Organization	Amneal Pharmaceuticals
Employees	7850
CEO	Mr. Chirag K. Patel
Industry	Health Technology

Management People of Amneal Pharmaceuticals

Name	Title
Mr. Chirag K. Patel	Co-Founder, Co-CEO, President & Director
Mr. Chintu Patel R.Ph.	Co-Founder, Co-CEO & Director
Mr. Anastasios G. Konidaris	Executive VP & CFO
Mr. Jason B. Daly Esq.	Senior VP, Chief Legal Officer & Corporate Secretary
Ms. Nikita Shah	Executive VP & Chief Human Resources Officer
Mr. Andrew S. Boyer	Executive VP & Chief Commercial Officer of Generics
Mr. Anthony DiMeo	Head of Investor Relations
Mr. Gregory Sgammato	Senior Vice President of Corporate Development
Mr. Pranav Mehta	Senior VP of Strategic Sourcing & Supply Management
Dr. Sanjay Kumar Jain Ph.D.	Chief Quality Officer

Important FAQs about investing in Amneal Pharmaceuticals (AMRX) from India :

What is Amneal Pharmaceuticals share price today?

Amneal Pharmaceuticals share price today stands at $8.82, Open: $8.45 ; Previous Close: $8.52 ; High: $9.04 ; Low: $8.42 ; 52 Week High: $9.48 ; 52 Week Low: $5.01. The stock opens at $8.45, after a previous close of $8.52. The stock reached a daily high of $9.04 and a low of $8.42, with a 52-week high of $9.48 and a 52-week low of $5.01.

Can Indians buy Amneal Pharmaceuticals shares?

Yes, Indians can invest in the Amneal Pharmaceuticals (AMRX) from India.

With INDmoney, you can buy Amneal Pharmaceuticals at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Amneal Pharmaceuticals at zero transaction cost.

How can I buy Amneal Pharmaceuticals shares from India?

It is very easy to buy Amneal Pharmaceuticals from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Amneal Pharmaceuticals be purchased?

Yes, you can buy fractional shares of Amneal Pharmaceuticals with INDmoney app.

What are the documents required to start investing in Amneal Pharmaceuticals stocks?

To start investing in Amneal Pharmaceuticals, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.